Effects of repeated administration of N-[1 -(2-benzo(b)-thiophenyl)cyclohexyl]piperidine and cocaine on locomotor activity in C57BL/6 mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 904-911

  Prinssen, Eric P M ^a   Kleven, Mark S ^a   Vignon, Jacques ^b   Kamenka, Jean Marc ^c   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b Inst Natl S la Rech Med U 336

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; PIPERIDINE DERIVATIVE; SODIUM CHLORIDE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; TIME;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; PIPERIDINES; SODIUM CHLORIDE; TIME FACTORS;

EID: 0030111423     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. AKUNNE, H. C., DERSCH, C. M., CADET, J. L., BAUMANN, M. H., CHAR, G. U , PARTILLA, J. S., DE COSTA, B. R., RICE, K. C., CARROLL, F. I. AND ROTHMAN, R. B.: Studies of the biogenic amine transporters. III Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes. J. Pharmacol. Exp. Ther. 268: 1462-1475, 1994.
2. BALDO, B. A. AND KELLEY, A. E.: Cross-sensitization between cocaine and GBR 12909, a dopamine uptake inhibitor. Brain Res. Bull. 27: 105-108, 1991.
3. BERGMAN, J., MADRAS, B. K., JOHNSON, S. E. AND SPEALMAN, R D.: Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251: 150-155, 1989.
4. CABIB, S.: Strain-dependent behavioural sensitization to amphetamine: Role of environmental influences Behav. Pharmacol. 4: 367-374, 1993.
5. CAIN, S. T., GRIFF, D., JOYNER, C. M., ELLINWOOD, E H. AND NEMEROFF, C. B.: Chronic continuous or intermittent infusion of cocaine differentially alter the concentration of neurotensin-like immunoreactivity in specific rat brain regions Neuropsychopharmacology 8: 259-265, 1993.
6. DOWNS, A. W. AND EDDY, N. B.: The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46: 199-200, 1932.
7. FARFEL, G. M., KLEVEN, M. S., WOOLVERTON, W. L., SEIDEN, L. S. AND PERRY. B. D.: Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 578: 235-243, 1992.
8. FRAY, P J., SAHAKIAN, B. J., ROBBINS, T W., KOOB, G. F. AND IVERSEN, S. D.: An observational method for quantifying the behavioral effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 69: 253-259, 1980.
9. HE, X., RAYMON, L. P., MATTSON, M. V., ELDEFRAWI, M. E. AND DE COSTA, B. R.: Further studies of the structure-activity relationships of 1-[1-(2-benzo [b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencycliane binding sites. J. Med. Chem. 36: 4075-4081, 1993.
10. ILAGOUMA, A. T., MAURICE, T., DUTERTE-BOUCHER, D., CODERC, E., VIGNON, J., COSTENTIN, J. AND KAMENKA, J. M.: Arylcyclohexlamines derived from BTCP are potent indirect catecholamine agonists. Eur. J. Med. Chem. 28: 377-385, 1993.
11. INADA, T., POLK, K., PURSER, C., HUME, A., KOSKINS, B., HO, I. H. AND ROCKHOLD, R. W.: Behavioral and neurochemical effects of continuous infusion of cocaine in rats. Neuropharmacology 31: 701-708, 1992.
12. IZENWASSER, S., TERRY, P., HELLER, B., WITKIN, J. M. AND KATZ, J. L.: Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur. J. Pharmacol. 263: 277-283, 1994.
13. KALIVAS, P. W., SORG, B. A. AND HOOKS, M. S.: The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4: 315-334, 1993.
14. KING, G. R., JOYNER, C. M. AND ELLINWOOD, E. J.: Withdrawal from continuous or intermittent cocaine: Behavioral responsitivity to 5-HT1 receptor agonists. Pharmacol. Biochem. Behav. 45: 577-587, 1993.
15. KING, G. R., JOYNER, C. M. AND ELLINWOOD, E. J.: Continuous or intermittent cocaine administration: Effects of amantadine treatment during withdrawal. Pharmacol. Biochem. Behav. 47: 451-457, 1994.
16. KLEVEN, M. S., ANTHONY, E. W. AND WOOLVERTON, W. L.: Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254: 312-317, 1990.
17. KOEK, W. AND COLPAERT, F. C.: Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J. Pharmacol. Exp. Ther. 252: 349-357, 1990.
18. KOEK, W., COLPAERT, F. C., WOODS, J. H. AND KAMENKA, J. M.: The phencyclidine (PCP) analog N-(1-(2-benzo(B)thiophenyl)cyclohexyl)piperidme shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. J. Pharmacol. Exp. Ther. 250: 1019-1027, 1989.
19. KOFF, J. M., SHUSTER, L. AND MILLER, L. G.: Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J. Pharmacol. Exp. Ther. 268: 277-282, 1994.
20. KULLBACK, S.: Information Theory and Statistics, Dover, New York, 1968.
21. LEBEL, L. A., NOWAKOWSKI, J. T., MACOR, J. E., Fox, C. B. AND KOE, B. K.: Dopamine uptake inhibitory activity of novel tryptamine 5-HT1 receptor ligands Drug Dev. Res. 33: 413-421, 1994.
22. MARTIN-FARDON, R., KAMENKA, J. M., KOEK, W., PRIVAT, A. AND VIGNON, J.: Effect of chronic N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine (BTCP) on extracellular dopamine concentration: A microdialysis study. In Monitoring Molecules in Neuroscience. Proceedings of the 6th International Conference on In Vivo Methods, ed. by A. Louilot, T. Durkin, U. Spampinato and M Cador, pp. 102-102, Publi Typ, Gradignan, 1994.
23. 3H]TCP binding to high- and low-affinity sites. Eur. J. Pharmacol 192: 169-172, 1991.
24. 3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex. Neuropharmacology 30: 591-8, 1991a.
25. MAURICE, T., BARBANEL, G. AND VIGNON, J.: Endogeneous dopamine differently affects N-[1-(2-benzo(B)thiophenyl)cyclohexyl]piperidine and cocaine binding to the dopamine uptake complex. Gen. Pharmacol. 24: 191-194, 1993.
26. 3H]BTCP. Neurosci. Lett. 101: 234-238, 1989.
27. MAURICE, T., VIGNON, J., KAMENKA, J. M. AND CHICHEPORTICHE, R.: Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J. Neurochem. 56: 553-559, 1991b.
28. MEEHAN, S. M. AND SCHECHTER, M. D.: Premorbid behaviors produced by cocaine, ethanol and cocaethylene in the mouse. Gen. Pharmacol. 26: 99-106, 1995.
29. PILOTTE, N. S , SHARPE, L. G. AND KUHAR, M. J.: Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269: 963-969, 1994.
30. POST, R. M., WEISS, S. R. B , FONTANA, D. AND PERT, A.: Conditioned sensitization to the psychomotor stimulant cocaine. Ann. N.Y. Acad. Sci. 654: 386-399, 1992.
31. POST, R M., WEISS, S. R. B., PERT, A AND UHDE, T. W.: Chronic cocaine administration: Sensitization and kindling effects. In Cocaine: Clinical and Biobehavioral Aspects, ed. by S. Fisher, A. Raskin and E. H. Uhlenhuth, pp. 109-173, Oxford University Press, New York, 1987.
32. REITH, M. E. A.. Effect of repeated administration of various doses of cocaine and WIN 35,065-2 on locomotor behavior of mice. Eur. J. Pharmacol. 130: 65-72, 1986.
33. REITH, M. E. A., MEISLER, B E., SERSHEN, H. AND LAJTHA, A.: Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35: 1123-1129, 1986.
34. RITZ, M. C., LAMB, R. J., GOLDBERG, S. R. AND KUHAR, M. J.: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash. DC) 237: 1219-1223, 1987.
35. ROTHMAN, R. B., CADET, J. L., AKUNNE, H. C., SILVERTHORN, M. L., BAUMANN, M. H., CARROLL, F. I., RICE, K. C., DE COSTA, B. R., PARTILLA, J. S., WANG, J. B., UHL, G., GLOWA, J. R AND DERSCH, C. M . Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. J. Pharmacol. Exp. Ther. 270: 296-309, 1994.
36. ROTHMAN, R. B., LEWIS, B., DERSCH, C.,XU, H., RADESCA, L., DE COSTA, B. R., RICE, K. C., KILBURN, R. B., AKUNNE, H. C. AND PERT, A.: Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14: 34-39, 1993.
37. ROTHMAN, R. B., MELE, A., REID, A., AKUNNE, H., GREIG, N., THURKAUF, A., RICE, K C. AND PERT, A.: Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development. FEBS Lett. 257: 341-344, 1989.
38. SAADOUNI, S., REFAHI, L. F., COSTENTIN, J. AND BONNET, J. J.: Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. Eur. J. Pharmacol. Mol. Pharmacol. 268: 187-197, 1994.
39. 3H]mazindol-labeling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203: 141-144, 1991.
40. SHUSTER, L , Yu, G. AND BATES, A : Sensitization to cocaine stimulation in mice. Psychopharmacology 52: 185-190, 1977.
41. SLIMANI, M., BOUCHER, D., BONNET, J.-J., KAMSNKA, J.-M. AND CONSTENTIN, J.: Neurochemical and behavioral evidence for a central indirect dopaminergic agonist activity of GK13, a phencyclidine derivative. In Sigma and Phencyclidine-Like Compounds as Molecular Probes in Biology, ed. by E. F. Domino and J.-M. Kamenka, pp. 511-520, NPP Books, Ann Arbor, 1988.
42. SPEALMAN, R. D., MADRAS, B. K. AND BERGMAN, J.: Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 251: 142-149, 1989.
43. TATUM, A. L. AND SEEVERS, M H.: Experimental cocaine addiction. J. Pharmacol. Exp. Ther. 36: 401-110, 1929.
44. TOLLIVER, B. K., BELKNAP J. K., WOODS, W. E. AND CARNEY, J. M.: Genetic analysis of sensitization and tolerance to cocaine. J. Pharmacol. Exp. Ther. 270: 1230-1238, 1994.
45. TOLLIVER, B. K. AND CARNEY, J. M.: Comparison of cocaine and GBR 12935: Effects on locomotor activity and stereotypy in two inbred mouse strains. Pharmacol. Biochem. Behav. 48: 733-739, 1994a.
46. TOLLIVER, B. K. AND CARNEY, J. M.: Sensitization to stereotypy in DBA/2J but not C57BL/6J mice with repeated cocaine. Pharmacol. Biochem. Behav. 48: 169-173, 1994b.
47. TOLLIVER, B. K. AND CARNEY, J. M.: Locomotor stimulant effects of cocaine and novel cocaine analogs in DBA/2J and C57BL/6J inbred mice. Pharmacol. Biochem. Behav. 50: 163-169, 1995.
48. 3H]BTCP): A new phencyclidine analog selective for the dopamine uptake complex. Eur. J. Pharmacol. 148: 427-436, 1988.
49. WEISS, S., POST, R. M., PERT, A., WOODWARD, R. AND MURMAN, D.: Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression. Pharmacol. Biochem. Behav. 34: 655-661, 1989.
50. WINER, B. J.: Statistical Principles in Experimental Design, McGraw Hill, New-York, 1971.
51. XU, X. AND DOMINO, E. F.: Genetic differences in the locomotor response to single and daily doses of phencyclidine in inbred mouse strains. Behav. Pharmacol. 5: 623-629, 1994.